Skip to content

Cross-sectional research on QOL of hematopoietic stem cell transplant patient families

Cross-sectional research on QOL of hematopoietic stem cell transplant patient families - Cross-sectional research on QOL of hematopoietic stem cell transplant patient families

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047466
Enrollment
100
Registered
2022-04-18
Start date
2022-04-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Family of patients undergoing hematopoietic stem cell transplantation

Interventions

Questionnaire survey

Sponsors

Toranomon Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Received hematopoietic stem cell transplantation at our hospital from April 2008 to March 2022, and performed "Post-transplant LTFU & Vaccination Outpatient" or "Hematology Doctor's Outpatient" at least once from February 2022 to March 2023. Family of patients who have undergone an outpatient follow-up

Exclusion criteria

Exclusion criteria: Patient families that the attending physician deems inappropriate for this study

Design outcomes

Primary

MeasureTime frame
Caregiver Quality of Life Index-Cancer

Countries

Japan

Contacts

Public Contactmadoka narita

Toranomon Hospital Hematology

toraco@toranomon.gr.jp0335881111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026